FDA发布警告,将限制阿片类止痛药使用

2016-03-26 佚名 生物谷

在业内人士呼吁多年之后,近日FDA终于发表新指南,决定限制阿片类止痛药的使用,杜绝滥用。FDA在黑框警告中表示,阿片类止痛药的严重风险包括误用、滥用、成瘾、过量以及死亡。 FDA表示,由于羟考酮、氢可酮、吗啡等止痛药会造成患者成瘾,因此药品标签上应当注明,只有在非成瘾性止痛药不足以达到止痛效果时,医生才能够给患者开具这些速效止痛药处方。FDA将列出新的警告剂量,并且警告不要让已产生身体依赖的患者

在业内人士呼吁多年之后,近日FDA终于发表新指南,决定限制阿片类止痛药的使用,杜绝滥用。FDA在黑框警告中表示,阿片类止痛药的严重风险包括误用、滥用、成瘾、过量以及死亡。

FDA表示,由于羟考酮、氢可酮、吗啡等止痛药会造成患者成瘾,因此药品标签上应当注明,只有在非成瘾性止痛药不足以达到止痛效果时,医生才能够给患者开具这些速效止痛药处方。FDA将列出新的警告剂量,并且警告不要让已产生身体依赖的患者突然停止用药。速效止痛药占据目前止痛药处方的绝大部分比例。

FDA还指出,若女性在怀孕期间服用阿片类止痛药,则孩子出生后有可能出现新生儿阿片戒断综合症(NOWS)。这种情况有可能危及生命,因此需要医生第一时间做出诊断,然后让新生儿专家采取措施治疗。

FDA新任负责人Robert Califf表示,这次将是针对阿片类止痛药处方采取的最大规模措施之一,今年FDA还将进行一系列行动,来遏制目前阿片类止痛药滥用的情况。

今年二月份,就在Califf担任FDA负责人之前,他就表示FDA需要全面复审关于批准阿片类药物的政策。他还提出了8点计划,并指出新实行的政策重点在于既扭转当前阿片类药物滥用的局面,又能给那些真正需要阿片类止痛药的患者提供有效缓解疼痛的治疗。

一周之前,疾病预防控制中心(CDC)曾提出一个自愿性准则,旨在规范一线医护人员——如初级保健医生和内科医生助理过度开具高成瘾性药物处方的行为。CDC建议,对于那些短期的疼痛,医生们首先应该尝试非甾体类抗炎药和物理治疗。如果需要开具阿片类止痛药处方,首先应给予三天的最小剂量,并提示医生,有些患者对阿片类止痛药成瘾的速度会高于预期。

多年以来,FDA在阿片类药物监管方面受到许多批评。很多人认为FDA批准阿片类药物只基于其医疗用途是否有效,而忽视了其成瘾性。阿片类药物的滥用会导致成瘾者使用吗啡或海洛因,因为某种程度而言,它们比阿片类药物便宜。而过量服用导致的死亡率也在上升,根据CDC的调查,2000至2014年间,过量使用阿片类药物和吸食海洛因造成的死亡率上升了三倍

成瘾问题已经成为公共政策讨论的焦点,行政人员、执法人员和戒毒团体经常将成瘾归结为药企盲目扩张市场以及药品监管部门不作为共同造成的后果。

Califf提出的8点计划中强调,将要成立一个专家委员会,在审批阿片类新药时评估其成瘾性,作为最终是否获批的重要指标。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2017-01-24 卡圣

    物极必反

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=172250, encodeId=81201e225060, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Jan 24 05:09:58 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654690, encodeId=c6dc1654690a8, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Sat Aug 13 22:00:00 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75954, encodeId=5a58e595455, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75955, encodeId=6aa6e595542, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75956, encodeId=ec84e5956f3, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75957, encodeId=0691e59574c, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75958, encodeId=9e5ae595840, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75959, encodeId=d83ae5959d0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75960, encodeId=cb40e59604f, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75961, encodeId=53c4e596136, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Apr 06 12:53:00 CST 2016, time=2016-04-06, status=1, ipAttribution=)]
    2016-04-06 忠诚向上

    好好学习

    0

相关资讯

拜耳A型血友病药物Kovaltry获FDA批准

近日,美国FDA批准拜耳A型血友病药物Kovaltry上市,用于儿童和成人A型血友病患者。Kovaltry是一种是未经修饰的重组因子VIII化合物。 FDA此次积极监管意见主要依据一项名为LEOPOLD的长期临床试验研究,主要考察Kovaltry常规预防给药在成人、青少年和儿童A型血友病患者中的药动学、安全性和疗效,以及对围手术期出血护理的影响。FDA推荐Kovaltry在青少年和成人中剂量

国内还在用有粉医用手套么?美国或已全面封禁

美国FDA计划停用有粉医用手套小编从《今日医学新闻》中了解到常用于医学检查或临床诊断的一次性有粉医用手套将在美国率先全面封禁。医用手套主要有无粉末和有粉末两种之分。而有粉手套早期因其穿脱方便而受到医生的青睐,但关于有粉手套所致伤口肉芽肿及术后粘连等问题的报道不绝于耳,或基于此美国FDA终于下决心放“大招”。在21日公布了一项提议,拟在全美禁用医用有粉手套。“颁布这个禁令的主要目的是为了保护患者和医

美FDA掌门人出炉在即

在5个月的延迟后,美国参议院终于要为领导该国食品药品监督管理局(FDA)的候选人——心脏病学家、临床试验专家Robert Califf进行投票了。 2月22日,立法者投票支持限制就Califf提名展开的辩论。这一程序性策略为本周进行的将决定Califf是否领导FDA的最终投票作好了准备。 去年9月,总统巴拉克·奥巴马提名了Califf,但一些立法者出于对去年11月FDA将审批转基因三文鱼是否用

FDA批准银屑病治疗药Taltz

美国FDA批准Eli Lilly的Taltz (ixekizumab) 来治疗中度至重度斑块状银屑病。银屑病是一种皮肤发红和剥落的皮肤状况。银屑病是一种自身免疫性的紊乱,通常发生在家族史患者,最常在 15 至 35 岁开始。银屑病最常见的形式是斑块状银屑病,病人形成厚厚的红色皮肤片状,银白色鳞片状结构。 FDA 的药物评价和研究中心办公室主任医学博士Julie Bei

FDA批准的第一个3D打印处方药面市

Aprecia药物公司宣布, 第一个利用3D打印技术被FDA批准的处方药产品SPRITAM速溶片(左乙拉西坦)正式上市,用于治疗癫痫病发作。去年8月,SPRITAM得到了FDA的上市批准。 一、药品实现快速溶解,解决吞药难的问题 总部位于宾夕法尼亚的Aprecia制药公司,是全球唯一开发出3D打印药物的制药公司。粉液三维打印技术打印技术是麻省理工学院在20世纪80年代开发的技术。这种技术使

刘昌孝院士:生物医药全面开花

个体化治疗和免疫疗法成创新热点 2014年,美国食品药品监督管理局(FDA)审批的个性化药物仅占21%,2015年增长至28%,其中抗肿瘤药物增长至35%。这与业界对个性化药物优先审批有关。针对遗传性罕见病的新药的批准数量也在扩增,这反映了基因组学和个性化药物的进步。 数据分析认为,2016年,新研发的药物40%以上可能为个性化药物,今后这一比例还将会持续上升。2014年,